Search results
Author(s):
Anjali T Owens
Added:
9 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non…
View more
Michael B Fowler
Job title: Professor of Cardiovascular Medicine
Author
Muthiah Vaduganathan
Research Area(s) / Expertise:
Author
Expertise
Heart FailureHeart Failure ComorbiditiesChronic Heart Failure ManagementPrevention & Chronic ConditionsCardiovascular Kidney MetabolicChronic Kidney DiseaseHeart Failure and Chronic Kidney DiseaseHFpEF Pharmacological ManagementDiabetesHeart Failure and DiabetesHFmrEF Pharmacological ManagementObesityHypertensionMedication Optimisation and TitrationMetabolic dysfunction-associated fatty liver disease (MAFLD)StrokeHeart Failure Services, Prevention and Digital HealthHeart Failure Diagnosis and ImagingHeart Failure DevicesDemographicCardiomyopathiesEthnicityCardiomyopathies and Cardiac AmyloidosisGender
Faiez Zannad
Research Area(s) / Expertise:
Author
Expertise
Heart FailureHeart Failure ComorbiditiesChronic Heart Failure ManagementPrevention & Chronic ConditionsCardiovascular Kidney MetabolicChronic Kidney DiseaseHeart Failure and Chronic Kidney DiseaseHFpEF Pharmacological ManagementDiabetesHeart Failure and DiabetesHFmrEF Pharmacological ManagementObesityHypertensionMedication Optimisation and TitrationMetabolic dysfunction-associated fatty liver disease (MAFLD)StrokeHeart Failure Services, Prevention and Digital HealthHeart Failure Diagnosis and ImagingHeart Failure DevicesDemographicCardiomyopathiesEthnicityCardiomyopathies and Cardiac AmyloidosisGender
Myung H Park
Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Author
MicroRNAs for Cardiac Regeneration
Author(s):
Camilla Olianti
,
Mauro Giacca
Added:
9 months ago
Review Article
Massimiliano Camilli
Research Area(s) / Expertise:
Job title: Cardiologist
Author
Josip A Borovac
Research Area(s) / Expertise:
Job title: Cardiology Fellow and Clinical Investigator
Author
Clyde W Yancy
Research Area(s) / Expertise:
Author
Expertise
Heart FailureHeart Failure ComorbiditiesChronic Heart Failure ManagementPrevention & Chronic ConditionsCardiovascular Kidney MetabolicChronic Kidney DiseaseHeart Failure and Chronic Kidney DiseaseHFpEF Pharmacological ManagementDiabetesHeart Failure and DiabetesHFmrEF Pharmacological ManagementObesityHypertensionMedication Optimisation and TitrationMetabolic dysfunction-associated fatty liver disease (MAFLD)StrokeHeart Failure Services, Prevention and Digital HealthHeart Failure Diagnosis and ImagingHeart Failure DevicesDemographicCardiomyopathiesEthnicityCardiomyopathies and Cardiac AmyloidosisGender
Author(s):
Added:
1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the…
View more